Published in Genome Med on April 28, 2017
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep (2017) 0.75
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Human gut microbiome viewed across age and geography. Nature (2012) 19.31
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
Diet rapidly and reproducibly alters the human gut microbiome. Nature (2013) 11.04
The inflammatory reflex. Nature (2002) 9.10
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (2012) 6.66
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature (2015) 4.98
GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci (1988) 4.65
Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord (2014) 3.97
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett (2009) 3.48
Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett (2005) 3.30
Fast and sensitive protein alignment using DIAMOND. Nat Methods (2014) 3.22
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell (2016) 3.12
Ocean plankton. Structure and function of the global ocean microbiome. Science (2015) 3.08
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science (2010) 2.99
The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol (2012) 2.83
The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol (2012) 2.81
Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity (2014) 2.69
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci (2014) 2.59
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology (2010) 2.36
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One (2013) 2.24
ACLAME: a CLAssification of Mobile genetic Elements, update 2010. Nucleic Acids Res (2009) 2.07
Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci (2015) 1.94
The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One (2011) 1.90
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord (2011) 1.87
Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol (1990) 1.76
Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord (2012) 1.76
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One (2010) 1.72
Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med (2014) 1.60
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe (2015) 1.54
Healthy human gut phageome. Proc Natl Acad Sci U S A (2016) 1.47
Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One (2011) 1.40
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One (2015) 1.36
Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol (2013) 1.34
Diet-microbiota interactions as moderators of human metabolism. Nature (2016) 1.31
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ Health Perspect (2011) 1.30
Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One (2013) 1.30
Pathological lesions in colonic biopsies during Parkinson's disease. Gut (2008) 1.29
Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med (2015) 1.18
Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol (2013) 1.15
Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis (2015) 1.14
Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One (2013) 1.13
Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia (2014) 1.12
Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care (2014) 1.10
Colonic inflammation in Parkinson's disease. Neurobiol Dis (2012) 1.04
LotuS: an efficient and user-friendly OTU processing pipeline. Microbiome (2014) 1.03
A comparative analysis of the intestinal metagenomes present in guinea pigs (Cavia porcellus) and humans (Homo sapiens). BMC Genomics (2012) 1.01
Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol (2015) 1.00
Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol Ecol (2011) 0.98
The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J (2010) 0.96
Colonic bacterial composition in Parkinson's disease. Mov Disord (2015) 0.94
Microbiome-wide association studies link dynamic microbial consortia to disease. Nature (2016) 0.93
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol (2015) 0.92
The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience (2015) 0.89
Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol (2016) 0.89
Behçet's syndrome patients exhibit specific microbiome signature. Autoimmun Rev (2014) 0.88
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord (2016) 0.88
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos (2015) 0.86
Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome. Neuropsychopharmacology (2016) 0.86
Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease. Sci Rep (2015) 0.84
The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation. Front Microbiol (2016) 0.83
MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics (2016) 0.82
Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord (2013) 0.81
Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther (2016) 0.80
Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls. Mov Disord (2016) 0.80
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80
Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity. Autism Res (2015) 0.79
Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease. FEBS Lett (2015) 0.78
Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients (2016) 0.78
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Mov Disord (2017) 0.77
Towards biome-specific analysis of meta-omics data. ISME J (2015) 0.77
RTK: efficient rarefaction analysis of large datasets. Bioinformatics (2017) 0.76
Viral Safeguard: The Enteric Virome Protects against Gut Inflammation. Immunity (2016) 0.76
Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med (2016) 0.76
Species and tissue differences in serotonin glucuronidation. Xenobiotica (2015) 0.76